Massimo Bertinaria

8PUBLICATIONS
44CO-AUTHORS
Biologically active moleculesGene and molecular therapyAgricultural molecular engineering of nucleic acids and proteinsAutoimmunityBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 22, 2025
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-<i>b</i>]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Federica Blua, Francesca Boccato, Carola Buccellati

|Dec 11, 2022
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAF<sup>V600E</sup> Protein.

Elisabetta Marini, Marco Marino, Giulia Gionfriddo

|Jan 21, 2022
Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study.

Elisabetta Marini, Marta Giorgis, Marta Leporati

|Nov 27, 2021
Inflammasome Inhibitors.

Massimo Bertinaria

|Jul 02, 2021
Chemical Modulation of the 1-(Piperidin-4-yl)-1,3-dihydro-2<i>H</i>-benzo[d]imidazole-2-one Scaffold as a Novel NLRP3 Inhibitor.

Simone Gastaldi, Valentina Boscaro, Eleonora Gianquinto

|Aug 25, 2020
Ticagrelor Conditioning Effects Are Not Additive to Cardioprotection Induced by Direct NLRP3 Inflammasome Inhibition: Role of RISK, NLRP3, and Redox Cascades.

Claudia Penna, Manuela Aragno, Alessia Sofia Cento

Pageof 2

Frequent Collaborators

5 joint publications

Marta Giorgis

3 joint publications

Elisabetta Marini

2 joint publications

Federica Blua

2 joint publications

Barbara Rolando